How 25-Hydroxycholesterol Affects Cancer and Heart Cells
Author Information
Author(s): Lappano Rosamaria, Recchia Anna Grazia, De Francesco Ernestina Marianna, Angelone Tommaso, Cerra Maria Carmela, Picard Didier, Maggiolini Marcello
Primary Institution: Department of Pharmaco-Biology, University of Calabria, Rende, Italy
Hypothesis
Does 25-hydroxycholesterol activate estrogen receptor α-mediated signaling in cancer cells and cardiomyocytes?
Conclusion
25-hydroxycholesterol activates estrogen receptor α signaling, which may contribute to cancer progression and protect heart cells from hypoxia-induced apoptosis.
Supporting Evidence
- 25-hydroxycholesterol activates estrogen receptor α in a dose-dependent manner.
- It mimics the effects of estrogen in promoting cell proliferation in cancer cells.
- 25-hydroxycholesterol protects cardiomyocytes from hypoxia-induced apoptosis.
- It prevents the up-regulation of HIF-1α and CTGF in hypoxic conditions.
Takeaway
This study shows that a substance called 25-hydroxycholesterol can act like estrogen in certain cells, helping cancer cells grow and protecting heart cells from damage when there's not enough oxygen.
Methodology
The study involved experiments on breast and ovarian cancer cells and cardiomyocytes to assess the effects of 25-hydroxycholesterol on estrogen receptor signaling and gene expression.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website